These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31861604)

  • 21. Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
    Carmona-Bayonas A; Jiménez-Fonseca P; Echavarria I; Sánchez Cánovas M; Aguado G; Gallego J; Custodio A; Hernández R; Viudez A; Cano JM; Martínez de Castro E; Macías I; Martín Carnicero A; Garrido M; Mangas M; Álvarez Manceñido F; Visa L; Azkarate A; Ramchandani A; Fernández Montes A; Longo F; Sánchez A; Pimentel P; Limón ML; Arias D; Cacho Lavin D; Sánchez Bayona R; Cerdá P; García Alfonso P;
    Eur J Surg Oncol; 2018 Aug; 44(8):1191-1198. PubMed ID: 29685755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer statistics, 2018.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer.
    Van Daele E; Scuderi V; Pape E; Van de Putte D; Varin O; Van Nieuwenhove Y; Ceelen W; Troisi R; Pattyn P
    Acta Chir Belg; 2018 Aug; 118(4):227-232. PubMed ID: 29258384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
    Hong TS; Wo JY; Borger DR; Yeap BY; McDonnell EI; Willers H; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Tanguturi S; Goyal L; Murphy JE; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Tanabe KK; Ferrone CR; Ryan DP; Iafrate AJ; DeLaney TF; Zhu AX
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
    Al-Batran SE; Homann N; Pauligk C; Illerhaus G; Martens UM; Stoehlmacher J; Schmalenberg H; Luley KB; Prasnikar N; Egger M; Probst S; Messmann H; Moehler M; Fischbach W; Hartmann JT; Mayer F; Höffkes HG; Koenigsmann M; Arnold D; Kraus TW; Grimm K; Berkhoff S; Post S; Jäger E; Bechstein W; Ronellenfitsch U; Mönig S; Hofheinz RD
    JAMA Oncol; 2017 Sep; 3(9):1237-1244. PubMed ID: 28448662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma.
    Liu J; Wei Z; Wang Y; Xia Z; Zhao G
    ANZ J Surg; 2018 Apr; 88(4):E252-E256. PubMed ID: 27764891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic resection of non-colorectal non-endocrine liver metastases.
    Gandy RC; Bergamin PA; Haghighi KS
    ANZ J Surg; 2017 Oct; 87(10):810-814. PubMed ID: 27037839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series.
    Littrup PJ; Aoun HD; Adam B; Krycia M; Prus M; Shields A
    Abdom Radiol (NY); 2016 Apr; 41(4):767-80. PubMed ID: 26960728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis.
    Bai H; Huangz X; Jing L; Zeng Q; Han L
    Hepatogastroenterology; 2015; 62(138):373-7. PubMed ID: 25916066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases.
    Fode MM; Høyer M
    Radiother Oncol; 2015 Feb; 114(2):155-60. PubMed ID: 25583567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.
    Andreou A; Viganò L; Zimmitti G; Seehofer D; Dreyer M; Pascher A; Bahra M; Schoening W; Schmitz V; Thuss-Patience PC; Denecke T; Puhl G; Vauthey JN; Neuhaus P; Capussotti L; Pratschke J; Schmidt SC
    J Gastrointest Surg; 2014 Nov; 18(11):1974-86. PubMed ID: 25159501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy.
    Hiyoshi Y; Morita M; Kawano H; Otsu H; Ando K; Ito S; Miyamoto Y; Sakamoto Y; Saeki H; Oki E; Ikeda T; Baba H; Maehara Y
    Ann Surg Oncol; 2015 Jan; 22(1):240-6. PubMed ID: 25124469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy.
    Kutup A; Nentwich MF; Bollschweiler E; Bogoevski D; Izbicki JR; Hölscher AH
    Ann Surg; 2014 Dec; 260(6):1016-22. PubMed ID: 24950288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver metastases from esophageal carcinoma: is there a role for surgical resection?
    Huddy JR; Thomas RL; Worthington TR; Karanjia ND
    Dis Esophagus; 2015 Jul; 28(5):483-7. PubMed ID: 24898890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.
    Correa-Gallego C; Fong Y; Gonen M; D'Angelica MI; Allen PJ; DeMatteo RP; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2014 Dec; 21(13):4278-83. PubMed ID: 24889486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
    Wang J; Suri JS; Allen PK; Liao Z; Komaki R; Ho L; Hofstetter WL; Lin SH
    Am J Clin Oncol; 2016 Jun; 39(3):228-35. PubMed ID: 24710122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers - a case-controlled study.
    Slotta JE; Schuld J; Distler S; Richter S; Schilling MK; Kollmar O
    Int J Surg; 2014; 12(2):163-8. PubMed ID: 24342081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after recurrent esophageal carcinoma has not improved over the past 18 years.
    Blom RL; Lagarde SM; van Oudenaarde K; Klinkenbijl JH; Hulshof MC; van Laarhoven HW; Bergman JJ; Busch OR; van Berge Henegouwen MI
    Ann Surg Oncol; 2013 Aug; 20(8):2693-8. PubMed ID: 23549882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.